1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Guangzhou Kingmed Diagnostics Group Co., Ltd.
  6. News
  7. Sector news
    603882   CNE100002VW1

GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.

(603882)
  Report
End-of-day quote Shanghai Stock Exchange  -  05-19
82.72 CNY   +1.62%
04/29UBS Adjusts Guangzhou Kingmed Diagnostics' Price Target to 97 Yuan From 100 Yuan, Keeps at Buy
MT
04/26Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/20UBS Adjusts Guangzhou Kingmed Diagnostics' Price Target to 100 Yuan From 230 Yuan, Keeps at Buy
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Sector news Medical & Diagnostic Laboratories
05/20Nomura Adjusts Dr. Lal Pathlabs' Price Target to 1,771 Indian Rupees From 2,465 Rupees,..
MT
05/17TRANSCRIPT : Dr. Lal PathLabs Limited, Q4 2022 Earnings Call, May 17, 2022
CI
05/17Dr. Lal Pathlabs Limited Proposes Final Dividend for the Year Ended March 31, 2022
CI
05/13TRANSCRIPT : Diagnósticos da América S.A., Q1 2022 Earnings Call, May 13, 2022
CI
05/13SYNLAB : Receives a Buy rating from Deutsche Bank
MD
05/13SYNLAB : JP Morgan sticks Neutral
MD
05/12SYNLAB : Barclays reiterates its Buy rating
MD
05/12TRANSCRIPT : SYNLAB AG, Q1 2022 Earnings Call, May 12, 2022
CI
05/12SYNLAB : Gets a Neutral rating from JP Morgan
MD
05/12SYNLAB : Jefferies reaffirms its Buy rating
MD
05/12SYNLAB AG Revises Earnings Guidance for 2022
CI
05/12Diagnósticos da América S.A. Reports Earnings Results for the First Quarter Ended March..
CI
05/12SYNLAB AG Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/02DIAGNÓSTICOS DA AMÉRICA S.A.(BOVESPA : DASA3) added to Brazil Mid-Large Cap Index
CI
05/01Certain Ordinary Bearer Shares of SYNLAB AG are subject to a Lock-Up Agreement Ending o..
CI
04/26Certain Ordinary Bearer Shares of SYNLAB AG are subject to a Lock-Up Agreement Ending o..
CI
04/11Fitch Confirms Synlab's BB Rating Citing Large, Stable European Operations
MT
04/11SYNLAB : Deutsche Bank reiterates its Buy rating
MD
04/07Moody's Upgrades Synlab Outlook To Positive, Affirms Long-Term Rating
MT
03/28Diagnósticos da América S.A. Reports Earnings Results for the Full Year Ended December ..
CI
03/24SYNLAB AG (DB : SYAB) announces an Equity Buyback for 660,566 shares, for €16.51 mill..
CI
03/24SYNLAB AG authorizes a Buyback Plan.
CI
03/20DR. LAL PATHLABS LIMITED(BSE : 539524) added to FTSE All-World Index
CI
03/18SYNLAB : Gets a Buy rating from Barclays
MD
03/17SYNLAB : Deutsche Bank reiterates its Buy rating
MD
03/17SYNLAB : JP Morgan reiterates its Neutral rating
MD
03/16TRANSCRIPT : SYNLAB AG, Q4 2021 Earnings Call, Mar 16, 2022
CI
03/16SYNLAB : Mainfirst remains Neutral
MD
03/16SYNLAB : Receives a Buy rating from Goldman Sachs
MD
03/16SYNLAB : Receives a Buy rating from Jefferies
MD
03/16SYNLAB : JP Morgan sticks Neutral
MD
03/13Australian shares jump 1% on banking, energy boost
RE
03/04SYNLAB AG (DB : SYAB) acquired Institute for Pathology and Molecular Pathology Pforzheim.
CI
02/21Sonic Healthcare Limited authorizes a Buyback Plan.
CI
02/20Sonic Healthcare Reports Higher Fiscal H1 Profit, Revenue; Shares Down 5%
MT
02/20Sonic Healthcare Seeks Acquisitions
CI
02/20TRANSCRIPT : Sonic Healthcare Limited, H1 2022 Earnings Call, Feb 21, 2022
CI
02/20Sonic Healthcare's 1st Half Profit Up 22%, to Launch A$500 Million Share Buyback
DJ
02/20Sonic Healthcare Limited announces an Equity Buyback for AUD 500 million worth of its s..
CI
02/20Sonic Healthcare Limited Announces Dividend for the Six Months Ended December 31, 2021,..
CI
02/20Sonic Healthcare Limited Reports Earnings Results for the Half Year Ended December 31, ..
CI
02/10TRANSCRIPT : Dr. Lal PathLabs Limited, Q3 2022 Earnings Call, Feb 10, 2022
CI
01/17SYNLAB : Raised to Buy by Barclays
MD
01/13Brazil's Rede D'or and Bueno family bid for UnitedHealth's Amil - report
RE
01/12Diagnósticos da América S.A. agreed to acquire Marimed Serviços Médicos S.A.
CI
01/12Diagnósticos da América S.A. agreed to acquire AmeriMed American Hospitals.
CI
01/11SYNLAB : JP Morgan sticks Neutral
MD
01/07SYNLAB : Jefferies reiterates its Buy rating
MD
01/07Synlab Buys Spain's Sistemas Genómicos to Boost Genetics Offering
MT
01/07SYNLAB AG (DB : SYAB) acquired Sistemas Genomicos S.L. from Ascires Biomedical Group.
CI
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.